MMedication Read More FDA will drop two-study requirement for new drug approvals, aiming to speed accessFebruary 19, 2026 WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
MMedication Read More FDA will drop two-study requirement for new drug approvals, aiming to speed accessFebruary 19, 2026 WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
MMedication Read More FDA commissioner’s drug review plan sparks alarmJanuary 17, 2026 WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored…
HHealthcare Read More Top FDA drug regulator plans to depart weeks into jobDecember 3, 2025 The nation’s top drug regulator, Richard Pazdur, has decided to retire three weeks after taking the job. Pazdur…
MMedication Read More Rick Pazdur to replace George Tidmarsh at FDA drug centerNovember 13, 2025 WASHINGTON (AP) — The Food and Drug Administration on Tuesday named a longtime regulator of cancer medicines to…
MMedication Read More FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’November 3, 2025 WASHINGTON (AP) — The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal…
MMedication Read More FDA takes aim at Hims & Hers, weight loss drugs in new advertising blitzSeptember 19, 2025 WASHINGTON – For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions…